JC
Jagmohanlal Chopra
About Jagmohanlal Chopra
Data last updated:
Jagmohanlal Chopra was a Director at Acg Pharma Technologies Private Limited (2010–2018), Director at Polmann India Limited (2015–2018) and Director at Ae Advisors Private Limited (2010–2018), and held 3 more directorships. The companies operate in Machinery and Equipment, Manufacturing and Business Services.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Jul 2010 | 1996 | ₹199 Cr (FY 2023) | Amalgamated | |
| Director | 04 Sep 2015 | 1993 | ₹508 Cr (FY 2024) | Active | |
| Director | 13 May 2010 | 2010 | ₹40.8 Lakh (FY 2018) | Amalgamated | |
| Director | 29 Sep 2006 | 1972 | ₹912 Cr (FY 2025) | Active | |
| Director | 13 May 2010 | 2010 | ₹1.2 Lakh (FY 2018) | Amalgamated | |
| Additional Director | 01 Oct 2006 | 1961 | ₹3,601 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jagmohanlal Chopra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jagmohanlal Chopra
Jagmohanlal Chopra was first appointed on 29 Sep 2006 as Director at Acg Pam Pharma Technologies Private Limited. The most recent appointment on record is 04 Sep 2015 at Polmann India Limited.
Jagmohanlal Chopra held 6 earlier board appointments: Acg Pharma Technologies Private Limited (Director, 20 Jul 2010 to 11 Jul 2018); Polmann India Limited (Director, 04 Sep 2015 to 11 Jul 2018); Ae Advisors Private Limited (Director, 13 May 2010 to 11 Jul 2018); Acg Pam Pharma Technologies Private Limited (Director, 29 Sep 2006 to 11 Jul 2018); Eh Advisors And Consultants Private Limited (Director, 13 May 2010 to 11 Jul 2018); and 1 more.